(NTLA) Intellia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Intellia Therapeutics | (NTLA) share price targets
Complete technical analysis of Intellia Therapeutics (NTLA) by charts plus indicators, forecast predictions and share price targets for Intellia Therapeutics (NTLA)
Intellia Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-14 View latest technical analysis
10 day averaged volume of Intellia Therapeutics is 2376380
| Date | Daily Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 10.70 | 9.86 | 10.93 | 9.82 | 2 times |
| 13 Thu Feb 2025 | 9.64 | 9.53 | 9.72 | 9.33 | 0.87 times |
| 12 Wed Feb 2025 | 9.51 | 9.01 | 9.58 | 8.96 | 1.069 times |
| 11 Tue Feb 2025 | 9.21 | 9.39 | 9.48 | 9.08 | 0.909 times |
| 10 Mon Feb 2025 | 9.58 | 9.92 | 9.97 | 9.47 | 0.843 times |
| 07 Fri Feb 2025 | 9.79 | 10.07 | 10.43 | 9.72 | 0.867 times |
| 06 Thu Feb 2025 | 10.13 | 10.63 | 10.73 | 10.07 | 1.086 times |
| 05 Wed Feb 2025 | 10.51 | 9.76 | 10.63 | 9.72 | 1.105 times |
| 04 Tue Feb 2025 | 9.62 | 9.55 | 9.79 | 9.41 | 1.043 times |
| 03 Mon Feb 2025 | 9.54 | 9.79 | 9.90 | 9.32 | 1.296 times |
Stock of Intellia Therapeutics (NTLA) has showed a significant upmove. This could be a good time to enter in this stock!
Share price targets for Intellia Therapeutics (NTLA)
| Target Type | Value |
| Downside Target | 8.96 |
| Downside Target | 9.25 |
| Downside Target | 9.55 |
| Downside Target | 9.93 |
| Upside Target | 10.73 |
| Upside Target | 11.34 |
| Upside Target | 11.46 |
| Upside Target | 12.82 |
| Upside Target | 13.34 |
| Upside Target | 13.95 |
| Upside Target | 15.29 |
| Upside Target | 17.83 |
| Upside Target | 21.47 |
Intraday share price targets for Intellia Therapeutics (NTLA)
| Target Type | Value |
| Downside Intraday Target | 9.46 |
| Downside Intraday Target | 8.23 |
| Upside Intraday Target | 11.43 |
| Upside Intraday Target | 12.17 |
| Downside Intraday Target | 10.2 |
Weekly technical analysis of Intellia Therapeutics (NTLA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 10.70 | 9.92 | 10.93 | 8.96 | 1.054 times |
| 07 Fri Feb 2025 | 9.79 | 9.79 | 10.73 | 9.32 | 1.01 times |
| 31 Fri Jan 2025 | 10.32 | 10.29 | 10.77 | 9.93 | 0.963 times |
| 24 Fri Jan 2025 | 10.99 | 9.60 | 11.46 | 9.55 | 3.956 times |
| 17 Fri Jan 2025 | 9.50 | 9.48 | 9.69 | 9.32 | 0.192 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Intellia Therapeutics (NTLA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 14 Fri Feb 2025 | 10.70 | 9.79 | 10.93 | 8.96 | 0.387 times |
| 31 Fri Jan 2025 | 10.32 | 11.88 | 13.34 | 9.25 | 1.869 times |
| 31 Tue Dec 2024 | 11.66 | 14.90 | 15.29 | 11.34 | 0.648 times |
| 26 Tue Nov 2024 | 14.73 | 14.21 | 17.83 | 12.82 | 0.92 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.91 and Intellia Therapeutics (NTLA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.91 and Intellia Therapeutics (NTLA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.